Frontiers in Genetics

Researchers from Japan’s Osaka University and Switzerland’s University of Lausanne explored the ethical considerations and current status of cancer multigene panel testing access in their countries. Despite cultural and healthcare differences, they found common national barriers: limited test availability, insufficient patient information, and variable insurance coverage. The study underscores the need for more equitable genetic medicine, suggesting improvements in test access, patient education, and insurance policies.